E ndometrial cancer is the fourth most common cancer diagnosed in women in the United States in 2021 and has shown increases in death rates over the past decade. 1 Endometrial cancer was historically categorized as type I, endometrioid which is linked to obesity and estrogen excess, or type II, primarily serous, which is more common in older nonobese women. 2 Endometrial cancer is also surgically staged including hysterectomy, salpingo-oopherectomy with lymph node dissection or sampling, and omentectomy. For tumors with high-risk features that may increase risk for recurrence, adjuvant radiation, chemotherapy, or both are performed. However, pathologic accuracy can be limited particularly in high-grade subtypes and molecular classification is now utilized to offer accurate prognosis assessment. 3,4 Under the system of molecular classification 4 distinct subgroups have been identified including one group with mismatch repair (MMR) deficiency which leads to microsatellite instability (MSI).In general, tumors with high MSI or MMR deficiency have better response to immunotherapy agents. 5 Before molecular classification, mismatch repair deficiency was tested in endometrial cancer patients to identify patients with Lynch syndrome. 6 Microsatellite instability testing is now reflexive in the treatment of endometrial cancer. MMR deficiency is normally determined from biopsy or surgical samples. However, despite the use of molecular classification and treatment of tumors with microsatellite instability with targeted immunotherapy treatment, some patients with endometrial cancer with MSI-high/MMR deficiency continue to progress. 6 Thus, biopsy, surgical staging, and molecular categorization may still be providing an incomplete picture of the true nature of endometrial cancers. There is still a need for better characterization of endometrial cancer, which may be a role that can be fulfilled with molecular imaging. There has been interest in developing functional MRI techniques, which can complement molecular testing, pathology, and other diagnostic tools in tumor characterization. Ma et al in this article utilized